The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions July 27, 2012
Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial January 31, 2012
A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department September 1, 2011
Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain August 1, 2011
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer January 3, 2011
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders September 10, 2010
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression August 9, 2010
Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5-HT in the UK January 29, 2009
Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members July 27, 2007
